108 related articles for article (PubMed ID: 10601836)
61. Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected].
Beardsmore DM; Verbeke CS; Davies CL; Guillou PJ; Clark GW
J Gastrointest Surg; 2003 Jan; 7(1):77-86; discussion 86-7. PubMed ID: 12559188
[TBL] [Abstract][Full Text] [Related]
62. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
Allal AS; Waelchli L; Bründler MA
Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
[TBL] [Abstract][Full Text] [Related]
63. Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis.
Kimura S; Kitadai Y; Kuwai T; Tanaka S; Hihara J; Yoshida K; Toge T; Chayama K
Pathobiology; 2005; 72(4):179-85. PubMed ID: 16127293
[TBL] [Abstract][Full Text] [Related]
64. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
[TBL] [Abstract][Full Text] [Related]
65. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
66. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
Wu X; Cai ZD; Lou LM; Zhu YB
Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444
[TBL] [Abstract][Full Text] [Related]
67. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
Lam KY; Law S; Tin L; Tung PH; Wong J
Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
[TBL] [Abstract][Full Text] [Related]
68. Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Kurabayashi A; Sasaguri S; Araki K; Hayashi H; Ohtsuki Y
Oncology; 2004; 67(2):143-50. PubMed ID: 15539919
[TBL] [Abstract][Full Text] [Related]
69. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
70. Accumulation of p53 in esophageal squamous cell carcinoma.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
[TBL] [Abstract][Full Text] [Related]
71. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report.
Hellquist HB; Olejnicka B; Jadner M; Andersson T; Sederholm C
Br J Cancer; 1997; 76(2):175-9. PubMed ID: 9231916
[TBL] [Abstract][Full Text] [Related]
72. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis.
Ohbu M; Saegusa M; Kobayashi N; Tsukamoto H; Mieno H; Kakita A; Okayasu I
Cancer; 1997 Apr; 79(7):1287-93. PubMed ID: 9083148
[TBL] [Abstract][Full Text] [Related]
73. p53 and cyclin A protein expression in squamous carcinoma of the oesophagus.
Chetty R; Simelane S
Pathol Oncol Res; 1999; 5(3):193-6. PubMed ID: 10491016
[TBL] [Abstract][Full Text] [Related]
74. Apoptosis associated with esophageal adenocarcinoma: influence of photodynamic therapy.
McGarrity TJ; Peiffer LP; Granville DJ; Carthy CM; Levy JG; Khandelwal M; Hunt DW
Cancer Lett; 2001 Feb; 163(1):33-41. PubMed ID: 11163106
[TBL] [Abstract][Full Text] [Related]
75. Induction of apoptosis in head-and-neck squamous carcinoma cells by gamma-irradiation and bleomycin is p53-independent.
Patel V; Ensley JF; Gutkind JS; Yeudall WA
Int J Cancer; 2000 Dec; 88(5):737-43. PubMed ID: 11072242
[TBL] [Abstract][Full Text] [Related]
76. Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types.
Ohbu M; Saegusa M; Okayasu I
Virchows Arch; 1995; 427(3):271-6. PubMed ID: 7496596
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of apoptosis of tumor and of apparently normal cells in human renal carcinoma.
Roman S; Petrusca D; Moldovan I; Paraoan M; Petrescu A; Damian D; Noica N; Sulica A
Immunol Lett; 1999 Mar; 67(1):15-22. PubMed ID: 10217201
[TBL] [Abstract][Full Text] [Related]
78. Analysis of thermochemotherapy-induced apoptosis and the protein expressions of Bcl-2 and Bax in maxillofacial squamous cell carcinomas.
Zhao J; Wang SZ; Tang XF; Liu N; Zhao D; Mao ZY
Med Oncol; 2011 Dec; 28 Suppl 1():S354-9. PubMed ID: 21104343
[TBL] [Abstract][Full Text] [Related]
79. Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus.
Koide N; Koike S; Adachi W; Amano J; Usuda N; Nagata T
Surg Today; 1997; 27(8):685-91. PubMed ID: 9306579
[TBL] [Abstract][Full Text] [Related]
80. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.
Itoi T; Yamana K; Bilim V; Takahashi K; Tomita F
Br J Cancer; 2004 Jan; 90(1):200-5. PubMed ID: 14710230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
